PAFSC’s 2nd Committee Recommends Orphan Drug Designation for 3 Products Including Thyroid Cancer Treatment

The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs recommended orphan drug designation for three products including Eisai’s lenvatinib mesylate for an expected indication of thyroid cancer at a meeting on July 20. Advanced thyroid cancer has...read more